Tuberculosis Testing for Healthy Adults

Trial Objective

Tuberculosis Testing for Healthy AdultsThe purpose of this study is to determine if a new blood test known as the VIDAS Interferon Gama Release Assay (VIDAS TB-IGRA)  is effective at diagnosing tuberculosis in people who show no symptoms of the disease. Researchers are comparing VIDAS TB-IGRA with other diagnostic tests known to accurately detect latent tuberculosis in traditionally healthy adults who are at a low risk for the infection. If researchers can swiftly identify TB in its inactive state, they can proactively begin treatment and substantially reduce the risk of patients developing the active disease.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Healthy adults who have not been exposed to tuberculosis.

Age: 18+    Gender: Any Gender


Estimated Time Commitment

1 clinic visit



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Megan Rosa

Megan Rosa
303.270.2615

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

bioMerieux

Principal Investigators

Co-Investigators


Request More Information

After limiting clinical research activity due to safety concerns about COVID-19, we are now restarting clinical research in stages. If you are interested in any of the clinical trials posted on our website, please request trial information. We will respond and share the timing for enrollment resuming. Learn More


*
*
*
*